With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.
As of July 2025Eli Lilly has a market cap of$697.85 Billion USD. This makes Eli Lilly the world's14th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
| Year | Marketcap | Change |
|---|---|---|
| 2025 | $697.85 B | -0.92% |
| 2024 | $704.31 B | 27.28% |
| 2023 | $553.36 B | 59.19% |
| 2022 | $347.61 B | 31.56% |
| 2021 | $264.22 B | 63.6% |
| 2020 | $161.50 B | 28.34% |
| 2019 | $125.84 B | 2.83% |
| 2018 | $122.38 B | 31.6% |
| 2017 | $92.99 B | 14.54% |
| 2016 | $81.19 B | -12.81% |
| 2015 | $93.12 B | 21.54% |
| 2014 | $76.62 B | 34.53% |
| 2013 | $56.95 B | 0.73% |
| 2012 | $56.54 B | 17.52% |
| 2011 | $48.11 B | 19.17% |
| 2010 | $40.37 B | -1.6% |
| 2009 | $41.03 B | -10.38% |
| 2008 | $45.78 B | -24.4% |
| 2007 | $60.56 B | 2.72% |
| 2006 | $58.95 B | -7.81% |
| 2005 | $63.95 B | -0.44% |
| 2004 | $64.23 B | -18.72% |
| 2003 | $79.03 B | 10.88% |
| 2002 | $71.27 B | -19.21% |
| 2001 | $88.22 B | -15.85% |
| 2000 | $104.84 B | 44.61% |
| 1999 | $72.50 B | -25.6% |
| 1998 | $97.44 B | 26.03% |
| 1997 | $77.32 B | 90.29% |
| 1996 | $40.63 B |
OnJul 1st, 2025 the market cap of Eli Lilly was reported to be:
| Name | Marketcap | Market capdifferencediff. | Country |
|---|---|---|---|
 Bristol-Myers Squibb BMY | $97.03 B | -86.10% |  USA |
 Merck MRK | $206.57 B | -70.40% | USA |
 Johnson & Johnson JNJ | $374.49 B | -46.34% | USA |
 Pfizer PFE | $142.44 B | -79.59% | USA |
 Sanofi SNY | $119.24 B | -82.91% |  France |
 GlaxoSmithKline GSK | $77.81 B | -88.85% |  UK |
 AbbVie ABBV | $334.86 B | -52.01% | USA |
 Amgen AMGN | $156.56 B | -77.56% | USA |
 Novartis NVS | $244.68 B | -64.94% |  Switzerland |
 AstraZeneca AZN | $219.02 B | -68.61% | UK |
The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.
CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from theCompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.
© 2025 CompaniesMarketcap.com
Deutsch
